Find latest CLL videos · 80+ videos
MyCancerHaven
R

CLL and MCL: Experts Discuss the Use of Pirtobrutinib

By MyCancerHaven FEATURING Ravi Vij, Geoffrey Shouse
By MyCancerHaven FEATURING Ravi Vij, Geoffrey Shouse
240 views
May 7, 2024

Chapters

BTK Inhibitors & Pirtobrutinib's Role

00:00

Transitional Therapies: Overcoming BTK Resistance

03:32

MCL: FDA Approval & BRUIN Study Results

04:12

Pirtobrutinib Integration in MCL Treatment

08:02

CLL Treatment: Trial Design & Patient Demographics

09:23

CLL: Efficacy & Durability of Responses on Pirtobrutinib

12:26

Treatment Sequencing & Future of CLL Therapy

14:24

Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Videos

21:28

New

Choosing BTKi or BCL2i or Combination Therapy for 1L CLL

Danielle Brander

308 views
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.3K views
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

350 views
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

842 views
17:24

ESMO 2024 Summary: Updates in the Treatment of MCL

2024 ESMO Annual Meeting Insights Hub

G. Hess

240 views
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

502 views
15:17

Sequencing Therapies in CLL: The Importance of First-Line Treatment …

Nicole Lamanna

260 views
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

317 views
12:18

Debates in CLL: Continuous or Finite Duration Therapy

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Jain

163 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

912 views
25:47

Practice-Changing Updates in Indolent B-Cell Lymphomas

Massachusetts General Hospital Cancer Center

J. Soumerai

454 views
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

618 views
14:34

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Northwestern Medicine Oncology and Hematology

L. Gordon

389 views
18:29

Single vs. Multiple Agents in 2L Therapy for CLL

SOHO Brazil 2024

J. Burger

349 views
19:14

Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and E…

2024 ASCO® Annual Meeting Insights Hub

K. Rogers, J. Woyach

309 views
14:13

New

Pirtobrutinib in CLL: Current and Potential Utility in the Treatment…

Nicole Lamanna

81 views
18:15

The Next Frontier of Targeted Therapy in Lymphoma

UChicago Medicine

K. Maddocks

236 views
08:42

Venetoclax vs. BTKis in CLL Treatment

City of Hope

A. Danilov

254 views
14:22

Impact of Ibrutinib Dose Modifications in CLL

Ruemu Birhiray

293 views
15:26

New

Guideline-Based Treatment Approaches in CLL

Farrukh Awan

78 views
AUTOPLAY